Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 225 recruiting now early-phase tilt #2 of 28,963 conditions

Healthy: early-phase trial registry

225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2 of 28,963 conditions by registered trial count.

1,096 US clinical trials · 225 currently recruiting · #2 of 28,963 conditions by registered trial count

Healthy: 1,096 US clinical trials tracked, 225 recruiting.

Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.

Open enrollment, early-phase tilt

Healthy has 1,096 registered US clinical trials, 225 of them open to new participants right now, about 21% of the total.

225
recruiting participants now
21%
of trials open to enrollment
43
in Phase 3-4 (later-stage)
55
top sponsor: Eli Lilly and Company

Corpus placement: #2 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Healthy is recruiting below its size-band peers.

    225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Healthy trials is spread across many organizations.

    Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.

  3. Most Healthy trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.

  4. Healthy research is mostly interventional.

    905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1518Phase 228Phase 311Phase 432

Open and recent trials

1,096 total, page 22 of 22

COMPLETED 10 participants

Sex Differences in Gene Expression in Human Adipose Tissue

University of California, San Diego

NCT00677651

COMPLETED NA 10 participants

SpO2 Accuracy Comparison of Medline ReNewal Sensors to Arterial Blood CO-Oximetry

Medline Industries

NCT03565679

COMPLETED Phase 1 10 participants

Study to Evaluate Potential Food Effects

Procter and Gamble

NCT00791817

COMPLETED Phase 1 10 participants

Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers

Abbott

NCT00912431

COMPLETED NA 10 participants

White Adipose Tissue Clocks and High Calorie Feeding

University of Colorado, Denver

NCT02809482

COMPLETED 10 participants

Effect of Transcranial Magnetic Stimulation on Free Will

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00029653

COMPLETED Phase 2 9 participants

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

National Heart, Lung, and Blood Institute (NHLBI)

NCT00082329

COMPLETED NA 9 participants

Longvida Curcumin Human Pharmacokinetics Study

Clinical Nutrition Research Center, Illinois Institute of Technology

NCT03289507

COMPLETED NA 9 participants

Absorption and Metabolic Profiles of a Sugar-based Beverage

Clinical Nutrition Research Center, Illinois Institute of Technology

NCT02226250

COMPLETED NA 9 participants

Effect of Betaine and Food on Gastric pH

University of California, San Francisco

NCT02758015

COMPLETED Phase 1 8 participants

Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects

Galapagos

NCT04720183

COMPLETED Phase 1 8 participants

Study of the Absorption, Metabolism, and Excretion Following a Single Dose of [14C]-Poziotinib in Healthy Male Subjects

Spectrum Pharmaceuticals

NCT04436562

COMPLETED Phase 1 8 participants

A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)

Merck Sharp & Dohme

NCT06826989

COMPLETED NA 8 participants

Dietary Supplementation to Increase Serum Choline Levels

University of Colorado, Denver

NCT02403804

COMPLETED 8 participants

Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers

Abbott

NCT01126567

COMPLETED Phase 1 8 participants

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

Abbott

NCT00959816

COMPLETED Phase 1 8 participants

A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects

Janssen Research & Development

NCT03025022

COMPLETED Phase 1 8 participants

Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects

Pfizer

NCT01794364

COMPLETED Phase 1 8 participants

A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male Participants

Janssen Research & Development

NCT02692677

COMPLETED Phase 1 8 participants

A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects

Bristol-Myers Squibb

NCT02293629

COMPLETED Phase 1 8 participants

A Study of MK-1084 Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)

Merck Sharp & Dohme

NCT06687759

COMPLETED Phase 1 8 participants

Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants

Pfizer

NCT03974776

COMPLETED Phase 1 8 participants

Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration

Eli Lilly and Company

NCT03040362

COMPLETED Phase 1 7 participants

A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants

Eli Lilly and Company

NCT06052462

COMPLETED Phase 1 6 participants

A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy Participants

Janssen Research & Development

NCT03581916

COMPLETED 6 participants

Finger Muscle Reaction After Electrical Stimuli to the Human Finger Pulley System; a Pilot Study

Mayo Clinic

NCT01456871

COMPLETED Phase 1 6 participants

Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS

Yale University

NCT02124941

COMPLETED Phase 1 6 participants

AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184

Shire

NCT01824446

COMPLETED Phase 1 6 participants

Metabolism and Excretion of [14C]-Rigosertib After Infusion to Volunteers

Traws Pharma

NCT02030639

COMPLETED 6 participants

A Novel Fecal Sample Collection Method for Metagenomic Analyses

Onegevity Health

NCT05172414

COMPLETED Phase 1 6 participants

A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers

Tioga Pharmaceuticals

NCT01380561

COMPLETED Phase 1 6 participants

Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects

Pfizer

NCT03448172

COMPLETED Phase 1 6 participants

A Pharmacokinetic Study of MABp1 in Healthy Volunteers

Janssen Research & Development

NCT03047317

COMPLETED Phase 1 6 participants

A Study of LY3214996 in Healthy Participants

Eli Lilly and Company

NCT04033341

COMPLETED 5 participants

The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study

Stony Brook University

NCT02801643

COMPLETED Phase 1 5 participants

A Study To Investigate The Taste Of Crizotinib Liquid In Trained Healthy Adult Volunteers

Pfizer

NCT01125904

COMPLETED 4 participants

Pilot Study for Imaging of the Esophagus Using Tethered Capsule OCT Endomicroscopy With Distal Scanning

Massachusetts General Hospital

NCT02947997

COMPLETED Phase 1 4 participants

Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of Esreboxetine

Pfizer

NCT00800956

COMPLETED Phase 1 4 participants

Effect of Octreotide on Saliva

Duke University

NCT05340192

COMPLETED Phase 1 4 participants

A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants

Eli Lilly and Company

NCT04392271

COMPLETED Phase 1 2 participants

The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)

Vanderbilt University Medical Center

NCT03063476

COMPLETED Phase 1

Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen

Wyeth is now a wholly owned subsidiary of Pfizer

NCT00366262

COMPLETED

Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density

University of Wisconsin, Madison

NCT00205036

COMPLETED Phase 1

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects

Torrent Pharmaceuticals Limited

NCT00932763

COMPLETED NA

Home Safety Intervention Using a Safe Home Model

Ann & Robert H Lurie Children's Hospital of Chicago

NCT00824486

COMPLETED NA

Probiotic Formula and Infant Growth

Société des Produits Nestlé (SPN)

NCT01476397

← Previous Page 22 of 22

Phase Distribution

PhaseTrial count
Phase 1 518
Phase 2 28
Phase 3 11
Phase 4 32

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Healthy right now

225 recruiting of 1,096 indexed (21% open).

Phase mix: 43 late (III/IV) vs 546 early (I/II) (early-phase heavy).

Top sponsor: Eli Lilly and Company (55 trials), 9 others listed. 46 shown below, recruiting first. #2 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Healthy?

PlainTrial tracks 1,096 US clinical trials for Healthy, of which 225 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Healthy?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.